A study on drug product approval by the FDA from 1930 to 2019
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Tesis |
| Lenguaje: | English |
| Publicado: |
Brac University
2023
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/10361/18100 |
| id |
10361-18100 |
|---|---|
| record_format |
dspace |
| spelling |
10361-181002023-04-06T21:01:51Z A study on drug product approval by the FDA from 1930 to 2019 Jony, Md. Nazmul Islam Karim, Eshaba Department of Pharmacy, Brac University FDA Chronic Diseases Global Prevalence Unique API List ATC codes Therapeutic Classes United States. Food and Drug Administration. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis. Includes bibliographical references (pages 29-30). The Food and Drug Administration (FDA) is responsible for protecting and ensuring the safety of the American public health by approving and monitoring drug products. They do so with strict supervision. This study was done to find out any correlation between drug products approved by FDA and the nature of disease. Since chronic diseases are growing in global prevalence and directly threatening the health of the world population, this study attempted to identify if the most frequently approved drug products are for the treatment of such diseases. Data was collected from the official FDA website and analyzed to find out how frequently products containing each active pharmaceutical ingredient were approved. The ATC codes for the APIs were enlisted. This was used to identify their therapeutic classes. Most of the therapeutic classes suggested that the FDA has indeed approved more drug products for the treatment of chronic diseases than acute diseases. Md. Nazmul Islam Jony B. Pharmacy 2023-04-06T08:19:58Z 2023-04-06T08:19:58Z 2021 2021-02 Thesis ID: 16146041 http://hdl.handle.net/10361/18100 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 30 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
FDA Chronic Diseases Global Prevalence Unique API List ATC codes Therapeutic Classes United States. Food and Drug Administration. |
| spellingShingle |
FDA Chronic Diseases Global Prevalence Unique API List ATC codes Therapeutic Classes United States. Food and Drug Administration. Jony, Md. Nazmul Islam A study on drug product approval by the FDA from 1930 to 2019 |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. |
| author2 |
Karim, Eshaba |
| author_facet |
Karim, Eshaba Jony, Md. Nazmul Islam |
| format |
Thesis |
| author |
Jony, Md. Nazmul Islam |
| author_sort |
Jony, Md. Nazmul Islam |
| title |
A study on drug product approval by the FDA from 1930 to 2019 |
| title_short |
A study on drug product approval by the FDA from 1930 to 2019 |
| title_full |
A study on drug product approval by the FDA from 1930 to 2019 |
| title_fullStr |
A study on drug product approval by the FDA from 1930 to 2019 |
| title_full_unstemmed |
A study on drug product approval by the FDA from 1930 to 2019 |
| title_sort |
study on drug product approval by the fda from 1930 to 2019 |
| publisher |
Brac University |
| publishDate |
2023 |
| url |
http://hdl.handle.net/10361/18100 |
| work_keys_str_mv |
AT jonymdnazmulislam astudyondrugproductapprovalbythefdafrom1930to2019 AT jonymdnazmulislam studyondrugproductapprovalbythefdafrom1930to2019 |
| _version_ |
1814309058652405760 |